William Duke

Director of Finance/CFO at INVIVYD, INC.

Net worth: 161 335 $ as of 31/08/2026

53 year

60 connections

Health Technology

Consumer Services

Communications

Profile

William E.
Duke is Chief Financial & Accounting Officer at Invivyd, Inc. since 2023.
Former roles include Chief Financial Officer at OTF Group, Inc.; Director-Finance & Accounting at Haemonetics Corp.
from 2008 to 2010; Senior Director-Finance at Genzyme Corp.
from 2010 to 2011; Chief Financial Officer at g8wave Holdings, Inc. from 2007 to 2008; Chief Financial Officer & Head-Investor Relations at Valeritas, Inc. in 2015; Chief Financial Officer, Secretary & Treasurer at Pulmatrix, Inc. from 2015 to 2019; Chief Financial & Accounting Officer at Kaleido Biosciences, Inc. from 2019 to 2022; and Chief Financial Officer at Apexigen, Inc. from 2022 to 2023.
Education includes an MBA from Bentley University and undergraduate studies at Stonehill College, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INVIVYD, INC. 0.06%	18/08/2026	168,937 ( 0.06% )	161 335 $	31/08/2026

William Duke active positions

Companies	Position	Start
INVIVYD, INC.	Director of Finance/CFO	01/09/2023

All active positions of William Duke

Former positions of William Duke

Companies	Position	End
APEXIGEN, INC.	Director of Finance/CFO	23/08/2023
KALEIDO BIOSCIENCES, INC.	Director of Finance/CFO	08/04/2022
PULMATRIX, INC.	Director of Finance/CFO	22/11/2019
VALERITAS INC	Director of Finance/CFO	01/06/2015
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Director of Finance/CFO	-

See the detail of William Duke's experience

Training of William Duke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Duke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Haemonetics Corp. Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
g8wave Holdings, Inc. g8wave Holdings, Inc. Specialty TelecommunicationsCommunications Provides planning, creating and executing effective mobile marketing campaigns and content distribution strategies	Communications
Bentley University Bentley University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stonehill College, Inc. Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OTF Group, Inc. OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
Valeritas, Inc. Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes	Health Technology
Pulmatrix, Inc. Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease	Health Technology
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome	Health Technology
Invivyd, Inc. Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases	Health Technology
Apexigen, Inc. Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer	Health Technology